Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients

Chest

Volumn 111, Issue 6, 1997, Pages 1691-1696

  Schenk, Thomas ^a   Ackermann, Jutta ^b   Brunner, Christoph ^a   Schenk, Peter ^a   Zojer, Niklas ^a   Roka, Sebastian ^a   Drach, Johannes ^a   Angerler, ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Bronchoscopy; Chromosomal aneuploidy; Cytology of lung neoplasms; Interphase cytogenetics; Lung cancer

Indexed keywords

ANEUPLOIDY; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; LUNG CANCER; PRIORITY JOURNAL;

EID: 0031000312     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1691     Document Type: Article

References (32)

1. Boring CC, Squires TS, Tong T. Cancer statistics 1993. CA Cancer J Clin 1993; 43:7-26
2. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S-33S
3. Bülzebruck H, Bopp R, Drings P, et al. New aspects in the staging of lung cancer. Cancer 1992; 70:1102-06
4. Ginsberg RJ, Kris MG, Armstrong JG. Non-small cell lung cancer. In: De Vita VT, Hellmann S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed. Philadelphia JB Lippincott, 1993; 673-723
5. Epstein DM. The role of radiologic screening in lung cancer. Radiol Clin North Am 1990; 28:489-95
6. Mulshine JL, Scott F. Molecular markers in early cancer detection: new screening tools. Chest 1995: 107(suppl 6): 280S-86S
7. Strauss GM, Gleason RE, Sugarbaker DJ. Chest X-ray screening improves outcome in lung cancer: a reappraised of randomized trials on lung cancer screening. Chest 1995; 107(suppl 6):270S-79S
8. Bechtel JJ, Kelley WR, Petty TL, et al. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program. Arch Intern Med 1994; 154:975-80
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67
10. Weinberg R. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res 1989; 49: 3713-21
11. Pinkel D, Strainne T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986; 83:2934-38
12. Fiegl M, Tueni C, Schenk T, et al. Interphase cytogenetics reveal a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer 1995; 72:51-5
13. Drach J, Angerler J, Schuster J, et al. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 1995; 86:3915-21
14. Hopman AHN, Ramaekers FCS, Raap AK, et al. In situ hybridization as a tool to study numeric chromosome aberrations in solid bladder tumors. Histochemistry 1988; 89:307-16
15. Kibbelaar RE, Kok F, Dreef EJ. et al. Statistical methods in interphase cytogenetics: an experimental approach. Cytometry 1993; 14:716-24
16. Eastmond DA, Piukel D. Detection of aneuploidy and aneuploidy inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat Res 1990; 234:303-18
17. Bentz M, Schröder M, Herz M, et al. Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. Leukemia 1993; 7:752-57
18. Yokota J, Wada M, Shimosato Y, et al. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 1987; 84:9252-56
19. Shiseki M, Kohno T, Adachi J, et al. Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosomes Cancer 1996; 17:71-7
20. Kim SY, Lee KJ, Hong SC, et al. Interphase cytogenetics of lung tumors using in situ hybridization: numericle aberrations. Korean J Intern Med 1994; 9:55-60
21. Ried T, Petersen I, Holtgreve-Grez H, et al. Mapping of multiple DNA gains and losses in primary small cell carcinomas by comparative genomic hybridization. Cancer Res 1994; 54:1801-06
22. Truong LD, Underwood RD, Greenberg SD, et al. Diagnosis and typing of lung carcinomas by cytopathologic methods: a review of 108 cases. Acta Cytol 1985; 29:379-84
23. Buccheri G, Barberis P, Delfino MS. Diagnostic, morphologic, and histopathologic correlates in bronchogenic carcinoma: a review of 1,045 bronchoscopic examinations. Chest 1991; 99:809-14
24. Zojer N, Fiegl M, Angerler J, et al. Interphase fluorescence in situ hybridisation improves the detection of malignant cells in effusions from breast cancer patients. Br J Cancer (in press)
25. Slaughter DP, Southwick HW, Smejkal W. 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1954; 6:963-68
26. Heyne KH, Lippman SM, Lee JJ, et al. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992; 10:1519-24
27. Sagman U, Lishner M, Maki E, et al. Second primary malignancies following diagnosis of small cell lung cancer. J Clin Oncol 1992; 10:1525-33
28. Smith AL, Hung J, Walker L, et al. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients. Br J Cancer 1996; 73:203-09
29. Voravud N, Shin DM, Ro JY, et al. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993; 53:2874-83
30. Sozzi G, Miozzo M, Doughi R, et al. Deletions of 17p and p53 mutations in preneoptastic lesions of the lung. Cancer Res 1992; 52:6079-82
31. Hung J, Kishimoto Y, Sugio K. et al. Allele-specific chromosome 3p deletions occur al an early stage in the pathogenesis of hing carcinoma. JAMA 1995; 273:558-63
32. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258:818-21